MedPath
HSA Approval

APO-CARBAMAZEPINE TABLET 200 mg

SIN05735P

APO-CARBAMAZEPINE TABLET 200 mg

APO-CARBAMAZEPINE TABLET 200 mg

April 8, 1991

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N03AF01

carbamazepine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

CARBAMAZEPINE

200 mg

Carbamazepine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-CARBAMAZEPINE TABLET 200 mg - HSA Approval | MedPath